Abstract
Use of chronic anticoagulation has increased recently, leading to more surgical intervention on patients taking chronic anticoagulation. This review discusses anticoagulation and the management of urolithiasis.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as:• Of importance
Rowen SB, Bailey DN, Bublitz CE, Anderson RJ. Trends in Anticoagulation for Atrial Fibrillation in the U.S.: An Analysis of the National Ambulatory Medical Care Survey Database. J Am Coll Cardiol. 2007;49:1561–5.
Starr A, Fessler CL, Grunkemeier G, He GW. Heart Valve Replacement Surgery: Past, Present and Future. Clin Exp Pharmacol Physiol. 2002;29(8):735–8.
Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803–9.
King SB, Smith SC, Hirshfeld JW, et al. 2007 focused Update of the ACC/AHA > SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Circulation. 2008;117:261–5.
Shpitz B, Plotkin E, Spindel Z, et al. Should Aspirin Therapy be Withheld Before Insertion and/or Removal of a Permanent Peritoneal Dialysis Catheter? Am Surg. 2002;68(9):762–4.
O’Riordan JM, Margey RJ, Blake G, O’Connell PR. Antiplatelet Agents in the Perioperative Period. Arch Surg. 2009;144(1):69–76.
Oscarsson A, Gupta A, Fredrikson M, et al. To Continue or Discontinue Aspirin in the Perioperative Period: A randomized Controlled Clinical Trial. BJA. 2010;104(3):305–12.
Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA Guideline on Management of Staghorn Calculi: Diagnosis and Treatment Recommendations. J Urol. 173: 1991
Kessaris DN, Bellman GC, Pardalidis NP, Smith AG. Management of Hemorrhage after Percutaneous Renal Surgery. J Urol. 1995;153:604–806.
Semins MJ, Bartik L, Chew BH, et al. Multicenter Analysis of Postoperative CT Findings after Percutaneous Nephrolithotomy: Defining Complication Rates. Urology. 2011;78(2):291–4.
Lee WJ, Smith AD, Cubelli GH, et al. Complications of Percutaneous Nephrolithotomy. AJR AM J Roentgenol. 1987;148(1):177–80.
• Kefer JC, Turna B, Stein RJ, Desai MM. Safety and Efficacy of Percutaneous Nephrostolithotomy in Patients on Anticoagulant Therapy. J Urol. 2009;181:144–8. This is a good review of the use of anticoagulation in PCNL patients and describes preoperative management algorithm.
Gross AJ, Bach T. Preoperative Percutaneous Stone Surgery in Patients Receiving Anticoagulant Therapy. J Endourol. 2009;23(10):1563–5.
Van Cangh P, Smith AD. Management of Difficult Kidney Stones. J Endourol. 2007;21(5):478–89.
Douketis JD, Berger PB, Dunn AS. The Perioperative Management of Antithrombotic Therapy: American College of Chest Surgeons Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:299S–339S.
Nutescu EA, Spinler SA, Wittkowsky A, et al. Low-Molecular Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings. Ann Pharmacother. 2009;43(6):1064–83.
• Turna B, Stein RJ, Smaldone MC, et al. Safety and Efficacy of Flexible Ureterorenoscopy and Holmium:YAG Lithotripsy for Intrarenal Stones in Anticoagulated Cases. J Urol 179: 1415-1419 (2008). This is the only paper to discuss ureteroscopic management of stones in patients on anticoagulation.
Skolarikos AA, Papatsoris AG, Mitsogiannis IC, et al. Current Status of Ureteroscopic Treatment for Urolithiasis. Int J Urol. 2009;16:713–7.
Eberli D, Chassot PG, Sulser T, et al. Urological Surgery and Antiplatelet Drugs after Cardiac and Cerebrovascular Accidents. J Urol. 2010;183(6):2128–36.
Inoue H, Kamphausen T, Bajanowski T, Trubner K. Massive Retroperitoneal Hemorrhage after Extracorporeal Shock Wave Lithotripsy. Int J Legal Med. 2011;125(1):75–9.
Katz R, Admon D, Pode D. Life-Threatening Retroperitoneal Hematoma Caused by Anticoagulant Therapy for Myocardial Infarction after SWL. J Endourol. 1997;11(1):23–5.
Disclosures
J. M. Riley: none. Dr. Timothy Averch has served as a consultant for Bard Medical.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riley, J.M., Averch, T.D. Stone Management for the Patient on Anticoagulation. Curr Urol Rep 13, 187–189 (2012). https://doi.org/10.1007/s11934-012-0243-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-012-0243-3